NCT05116189 2026-03-09KEYNOTE-B96Merck Sharp & Dohme LLCPhase 3 Active not recruiting643 enrolled 17 charts 1 FDA
NCT03740165 2025-10-22KEYLYNK-001Merck Sharp & Dohme LLCPhase 3 Active not recruiting1,367 enrolled 29 charts
NCT02134925 2025-09-10Vaccine Therapy in Treating Patients With Newly Diagnosed Advanced Colon PolypsNational Cancer Institute (NCI)Phase 2 Active not recruiting110 enrolled 12 charts
NCT03834493 2025-07-18KEYNOTE-641Merck Sharp & Dohme LLCPhase 3 Active not recruiting1,244 enrolled 21 charts